DK0457804T3 - M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop - Google Patents

M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop

Info

Publication number
DK0457804T3
DK0457804T3 DK90902943.1T DK90902943T DK0457804T3 DK 0457804 T3 DK0457804 T3 DK 0457804T3 DK 90902943 T DK90902943 T DK 90902943T DK 0457804 T3 DK0457804 T3 DK 0457804T3
Authority
DK
Denmark
Prior art keywords
monoclonal antibodies
csf
conformational epitope
neutralizing
recognize
Prior art date
Application number
DK90902943.1T
Other languages
English (en)
Inventor
Kirston E Koths
Robert F Halenbeck
Joseph W Wrin
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DK0457804T3 publication Critical patent/DK0457804T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90902943.1T 1989-02-10 1990-01-17 M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop DK0457804T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31004289A 1989-02-10 1989-02-10

Publications (1)

Publication Number Publication Date
DK0457804T3 true DK0457804T3 (da) 1996-09-23

Family

ID=23200753

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90902943.1T DK0457804T3 (da) 1989-02-10 1990-01-17 M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop

Country Status (9)

Country Link
US (1) US5491065A (da)
EP (1) EP0457804B1 (da)
JP (1) JP3001969B2 (da)
AT (1) ATE141290T1 (da)
CA (1) CA2008817C (da)
DE (1) DE69028095T2 (da)
DK (1) DK0457804T3 (da)
ES (1) ES2091816T3 (da)
WO (1) WO1990009400A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096540A (en) * 1996-09-30 2000-08-01 Becton Dickinson And Company Differentiation of granulocytic and monocytic progenitor cells
US6363129B1 (en) 1998-11-09 2002-03-26 Broadcom Corporation Timing recovery system for a multi-pair gigabit transceiver
WO2001034177A2 (en) * 1999-11-08 2001-05-17 The Government Of The United States Of America, A S Represented By The Secretary, Department Of Hea Lth & Human Services, The National Institutes Of Health Method of treating a viral infection using antagonists of macrophage colony stimulating factor
US7108852B2 (en) 2000-03-20 2006-09-19 Warner-Lambert Company Llc Methods of treating inflammation using antibodies to M-CSF
US20110091451A1 (en) * 2002-11-15 2011-04-21 Kavanaugh William M Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
CN1787837A (zh) * 2002-11-15 2006-06-14 希龙公司 防止和治疗癌转移以及与癌转移相关的骨质损失的方法
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
AU2005205533B2 (en) 2004-01-07 2012-03-22 Novartis Vaccines And Diagnostics, Inc. M-CSF-specific monoclonal antibody and uses thereof
AU2005255019B2 (en) * 2004-06-12 2011-05-19 Oregon Health And Science University Compositions and methods for diagnosis and treatment of orthopoxviruses
AR054428A1 (es) * 2005-03-08 2007-06-27 Pharmacia & Upjohn Co Llc Composiciones de anticuerpos anti factor estimulante de colonia de macrofagos (anti-m-csf) que tienen menores niveles de endotoxina
WO2007016285A2 (en) * 2005-07-28 2007-02-08 Novartis Ag M-csf specific monoclonal antibody and uses thereof
WO2007016240A2 (en) * 2005-07-28 2007-02-08 Novartis Ag Use of antibody to m-csf
EP1984024A2 (en) 2006-01-05 2008-10-29 Novartis AG Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
CA2841013C (en) 2011-07-18 2020-04-21 Morphosys Ag Use of c-fms antagonists
KR20150140752A (ko) 2013-04-12 2015-12-16 모르포시스 아게 M-csf를 표적으로 하는 항체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504586A (en) * 1983-02-03 1985-03-12 Amgen Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
HU212277B (en) * 1986-05-06 1996-04-29 Genetics Inst Process for producing m-csf
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1

Also Published As

Publication number Publication date
EP0457804B1 (en) 1996-08-14
CA2008817A1 (en) 1990-08-10
ATE141290T1 (de) 1996-08-15
JP3001969B2 (ja) 2000-01-24
WO1990009400A1 (en) 1990-08-23
ES2091816T3 (es) 1996-11-16
DE69028095D1 (de) 1996-09-19
CA2008817C (en) 2000-03-14
DE69028095T2 (de) 1997-02-06
JPH04503155A (ja) 1992-06-11
US5491065A (en) 1996-02-13
EP0457804A1 (en) 1991-11-27

Similar Documents

Publication Publication Date Title
ATE141290T1 (de) M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen
EP0914155A4 (en) PROSTATE SPECIFIC MEMBRANE ANTIGEN MONOCLONAL ANTIBODIES
DE69534235D1 (de) Cytokin lerk-7
DE68901632D1 (de) Reaktionsgefaess zur durchfuehrung von aufeinanderfolgenden analytischen testen.
ES2046462T3 (es) Marcadores de activacion de celulas "t".
FI944509A0 (fi) Interferonireseptorin vastaisia monoklonaalisia vasta-aineita, joilla on neutralisoivaa aktiivisuutta tyypin I interferonia vastaan
ATE250426T1 (de) Verwendung von verbindungen die an ein zytoplasmatischen dipeptidase binden zur potenzierung des immunantworts
ATE40602T1 (de) Immunchemisches messverfahren.
DE68928834D1 (de) Monoklonale antikörper gegen katzen-t-lymphotropes lentivirus
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
ES2050114T3 (es) Anticuerpos monoclonales humanos para el virus asociado a la linfoadenopatia.
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
SE8900899L (sv) Peptider foer diagnostisk anvaendning
DE68921360D1 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
ES2082132T3 (es) Composicion que contiene al menos dos anticuerpos distintos o fragmentos de ellos.
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
DE3886545D1 (de) Monoklonale human-antikörper, spezifisch für rh(d).
ATE73463T1 (de) Monoklonale antikoerper.
KR900017549A (ko) 암의 혈청진단법
ES8606500A1 (es) Un metodo para determinar la presencia de ige especifica en sueros humanos
DK31589A (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.